Key result
Intracoronary epinephrine restores blood flow and stabilizes hemodynamics in refractory no-reflow with cardiogenic shock.
Why the study?
Despite early reperfusion in STEMI, a significant number of patients experience the no-reflow phenomenon, a complication with an unfavorable prognosis whose treatment remains problematic.
Case Report (n=1)
No
This case report discusses the use of intracoronary epinephrine for managing the no-reflow phenomenon in a patient with cardiogenic shock.
May support intracoronary epinephrine in refractory no-reflow with shock; hypothesis-generating case report requiring prospective validation.
Vcasna reperfuzna terapia pri infarkte myokardu s elevaciou ST (STEMI) Pritomnosť noflow fenomenu predstavuje komplikaciu s nepriaznivou prognozou.
No takes yet. Share an insight, caveat, or question.
Dragula et al. (2020) conducted a case report in No-reflow phenomenon in cardiogenic shock complicating acute myocardial infarction (n=1). Intracoronary epinephrine was evaluated on Restoration of coronary blood flow and hemodynamics. Intracoronary administration of 200 μg of epinephrine successfully restored coronary blood flow and stabilized hemodynamics in a patient with refractory no-reflow phenomenon and cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: